Costs of conservative treatment of patients with cholangitis and cholesystitis
| Autor: | Danijela Stanković-Baričak, Tomislav Preveden, Sinisa Sevic, Vedrana Petrić, Sandra Stefan Mikić, Jelena Kalember |
|---|---|
| Rok vydání: | 2014 |
| Předmět: | |
| Zdroj: | Medical review. 67:44-51 |
| ISSN: | 1820-7383 0025-8105 |
| DOI: | 10.2298/mpns14s2044m |
| Popis: | Introduction. There are no guidelines for treating bacterial infections in our country. Antibacterial drugs are selected empirically, which is not always in accordance with the recommended therapy coming from the countries that have their own pharmacotherapy protocols. This study reviews the differences between the standard conservative treatment of cholangitis/cholecystitis and treatment implemented in accordance with current pharmacotherapy guidelines of other countries. The assessment of the therapeutic efficacy of antibacterial drugs implemented in the treatment of cholangitis/cholecystitis and economic viability of that implementation was one of the aims of this study, and another one was comparison of the efficiency and cost of medical treatment using physician’s therapy of choice and treatment according to pharmacotherapy guidelines. Material and Methods. The study was carried out over a threeyear period at the Department of Infectious Diseases of the Clinical Center of Vojvodina. It included 72 patients with the diagnosis of cholangitis/cholecystitis who were divided into two groups. The control group was treated according to the physician’s therapy of choice, while the test group was treated in accordance with pharmacotherapy guidelines. The efficiency and cost of medical treatment were determined for both groups. Results. The comparison of the efficiency and costs of medical treatment of cholangitis/cholecystitis before and after introducing pharmacotherapy guidelines showed no significant differences in the efficiency of administered therapies. However, the cost of medical treatment carried out in accordance with pharmacotherapy guidelines showed a decrease of 17.24%. Conclusion. Medical treatment using physician’s antibacterial therapy of choice and the one which is in accordance with pharmacotherapy guidelines for treating cholangitis/cholecystitis show no differences in terms of efficiency. However, medical treatment proved to be more affordable in the group of patients treated in accordance with pharmacotherapy guidelines of other countries. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|